Kanabo Group PLC
KNB
Company Profile
- Business description- Kanabo Group PLC is a research and development company engaged in selling a range of THC-Free retail CBD products in the markets and it is in the process of developing medical cannabis products. Its reportable segments include Primary Care and Secondary Care. The Primary Care segment, which derives key revenue, includes Tele pharma services provided by GPS and The Secondary Care segment includes the development and distribution of cannabis-derived medical and wellness products. Geographically company has a presence in the United Kingdom and Israel. 
- Contact- 137-139 Brent Street 
 Churchill House
 LondonNW4 4DJ
 GBR- T: +44 2074690930 
- Sector- Healthcare - Stock type- Defensive 
- Industry- Medical Care Facilities - Fiscal Year End- 31 December 2025 - Employees- 16 
Stocks News & Analysis
stocks
Are investors too bearish on Australian equities?
A new report suggests the pessimism might be overdone.
Morningstar Investment Ideas
Markets
| Index | Last price | Change | % Change | 
|---|---|---|---|
| All Ordinaries | 9,178.90 | 5.00 | 0.05% | 
| CAC 40 | 8,148.79 | 52.09 | -0.64% | 
| DAX 40 | 24,144.71 | 20.50 | 0.08% | 
| Dow JONES (US) | 47,836.10 | 204.10 | 0.43% | 
| FTSE 100 | 9,723.21 | 32.93 | -0.34% | 
| HKSE | 26,282.69 | 63.45 | -0.24% | 
| NASDAQ | 23,793.45 | 165.02 | -0.69% | 
| Nikkei 225 | 51,325.61 | 17.96 | 0.04% | 
| NZX 50 Index | 13,459.29 | 50.08 | 0.37% | 
| S&P 500 | 6,871.34 | 19.25 | -0.28% | 
| S&P/ASX 200 | 8,885.50 | 5.50 | 0.06% | 
| SSE Composite Index | 3,986.90 | 29.43 | -0.73% |